A new systematic literature review on patient quality of life in Alzheimer’s disease is now published. The study was co-authored by Anders Gustavsson and is part of the Innovative Medicines Initiative project ROADMAP. The study shows the systematically worse proxy-reported QoL estimates as compared to self-reported estimates across different stages of the disease. The article can be downloaded here.
